Mylan stock bounces back from early losses after CEO blames FDA for drug delays

Mylan’s stock bounced back in midday trading Wednesday from lower-than-expected second quarter earnings after the company’s management said its generic drug Advair is not being delayed by further FDA-required studies. After shares of the drug-maker dropped...

Maryland City May Let Noncitizens Vote, a Proposal With Precedent

By MAGGIE ASTOR August 9, 2017 As a federal commission searches for evidence of voter fraud and many states try to impose new voting restrictions, a city in Maryland may move in the opposite direction: allowing noncitizens to vote in local elections. In...